Acute telogen effluvium associated with SARS-CoV-2 infection
Aust J Gen Pract
.
2020 Aug 26:49.
doi: 10.31128/AJGP-COVID-32.
Authors
Miguel Domínguez-Santás
1
,
Lara Haya-Martínez
2
,
Diego Fernández-Nieto
3
,
Juan Jiménez-Cauhé
4
,
Ana Suárez-Valle
1
,
Borja Díaz-Guimaraens
1
Affiliations
1
MD, Dermotologist, Dermatology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
2
MD, Dermotologist, Dermatology Department, Fundación Jiménez Díaz, Madrid, Spain.
3
MD, Dermatologist, Dermatology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. fnietodiego@gmail.com.
4
MD, Dermatologist, Dermatology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.
PMID:
33051638
DOI:
10.31128/AJGP-COVID-32
Abstract
Acute telogen effluvium has been recognised as a dermatological sequela of COVID-19.
MeSH terms
Alopecia Areata*
COVID-19*
Humans
SARS-CoV-2